American International Group (AIG) Q1 2026 earnings review
M&A Engine Ignites Top-Line Surge, But Underlying Mix Shifts Require Scrutiny
AIG's strategic pivot from capital-return story to growth story is officially manifesting in the numbers. Driven by the Convex Group equity stake/quota share and the Everest Group retail renewals, Net Premiums Written (NPW) surged an accelerating 24% YoY. The bottom line followed suit: General Insurance Underwriting Income more than tripled to $774 million, propelled by a merciful drop in catastrophe losses ($180M vs $525M a year ago). Adjusted EPS skyrocketed 80% to $2.11, blowing past expectations. However, investors must look under the hood: the influx of new business mix slightly compressed underlying margins in the flagship North America Commercial segment.
🐂 Bull Case
NPW grew 24% YoY (18% constant dollar), a stark reversal from the flat to low-single-digit growth seen throughout 2025. The Everest and Convex transactions are immediately delivering the promised scale.
Core Operating ROE hit 12.2% (up from 7.7% a year ago), firmly above management's 10%+ Investor Day target. General Insurance combined ratio printed a stellar 87.3%.
🐻 Bear Case
Despite a 37% jump in premium, North America Commercial's Accident Year Combined Ratio (ex-CAT) worsened by 120 bps to 85.5%, suggesting the new Everest portfolio carries a higher underlying loss ratio.
Total Net Investment Income fell 36% YoY to $712M on a GAAP basis, driven by mark-to-market headwinds and the reduced stake in Corebridge Financial.
⚖️ Verdict: 🟢
Bullish. The strategic M&A execution is flawless so far. While mix shifts are pressuring underlying margins slightly in NA Commercial, the sheer volume of accretive premium growth and the massive drop in catastrophe exposure prove the 'AIG Next' transformation was successful.
Key Themes
Strategic Deals Translate to Accelerating Premium Growth
AIG's top line is accelerating dramatically. North America Commercial NPW skyrocketed 36% (constant dollar), International Commercial jumped 12%, and Global Personal grew 11%. Management explicitly attributed this to the Everest renewals, the Convex Group whole account quota share, and favorable reinsurance program changes. This confirms the narrative shift from 2025: AIG is now successfully deploying capital into accretive M&A rather than relying solely on buybacks.
Underlying Margin Deterioration in NA Commercial
While NA Commercial was the growth engine (+37% NPW), its Accident Year Combined Ratio (AYCR, ex-CAT) is decelerating, ticking up 120 basis points YoY to 85.5%. Management vaguely cited 'changes in business mix.' Connecting the dots: the integration of the Everest retail portfolio—which historically ran at a higher loss ratio—is diluting AIG's core underwriting margin. This is a critical metric to monitor to ensure top-line growth isn't destroying bottom-line quality.
Global Personal Turnaround
The Global Personal segment is showing a reversing trend in profitability. The combined ratio plummeted 1,850 basis points from a disastrous 107.9% in 25Q1 to a highly profitable 89.4% in 26Q1. Even stripping out favorable CAT variances, the underlying AYCR improved 570 bps to 89.9%. Management points to improved commission terms in the U.S. High Net Worth business and targeted underwriting actions.
Catastrophe Volatility Suppressed
Q1 is historically volatile (e.g., $525M in CAT losses in 25Q1 due to California wildfires), but 26Q1 CAT losses came in at just $180M (3.0 loss ratio points). This massive 6.1-point YoY tailwind to the loss ratio was the primary driver of the underwriting income tripling. Favorable January 1 reinsurance renewals, where AIG secured better pricing without sacrificing coverage, played a key role in shielding the balance sheet.
Corebridge Noise and GAAP Investment Income Drag
Total Net Investment Income on a GAAP basis was $712 million, down 36% YoY. This deceleration was primarily driven by fair value mark-to-market changes on equity securities and the reduced stake in Corebridge (now down to just 5.6% after a $750M share sale). While 'Adjusted Pre-Tax' NII actually rose 8% to $915 million, the GAAP noise continues to obscure the clean operating picture for retail investors.
Capital Returns Shifting to a 'Normalized' State
As signaled by management in late 2025, AIG has shifted from massive, multi-billion-dollar quarterly buybacks to a 'normalized' capital allocation framework focused on M&A. In 26Q1, AIG repurchased $519 million in shares—a stable but vastly reduced run-rate compared to the $2.2 billion repurchased in 25Q1. To offset the buyback deceleration, the Board hiked the dividend by 11% to $0.50 per share.
Other KPIs
Accelerating. Up from $64 million in the prior year quarter. The favorable development was concentrated in U.S. Property and U.S. Financial Lines, boosting the bottom line and indicating conservative reserving practices in prior periods.
Stable. The balance sheet remains highly unencumbered, providing ample dry powder to execute on the Onex $2 billion investment commitment and integrate the Convex quota share without stressing leverage.
Stable. Down 1% sequentially from Q4 2025, but up 6% YoY. Adjusted Tangible Book Value Per Share actually rose 1% sequentially to $70.85, reflecting the accretion of operating earnings over fair value adjustments.
Guidance
Accelerating. An 11% increase from prior quarterly dividends, marking the fourth consecutive year of double-digit percentage dividend hikes. Payable June 29, 2026.
Stable. Management explicitly reiterated confidence in meeting or exceeding the financial objectives outlined at the March 2025 Investor Day, supported by the 12.2% Core Operating ROE achieved this quarter.
Key Questions
Underlying Margins in NA Commercial
With the NA Commercial AYCR worsening by 120 bps due to 'mix shift,' how much of this is directly attributable to the Everest renewals, and what is the timeline for re-underwriting that portfolio to AIG's target sub-85% AYCR?
Casualty Reserving Post-Convex
The favorable $132M PYD came from Property and Financial Lines. Given industry-wide social inflation trends, are you still holding 'additional margin' in your casualty loss picks, and how does the new Convex quota share impact your net casualty exposure?
Corebridge Liquidation Timeline
With the Corebridge stake now down to 5.6% after the $750M Q1 sale, do you plan to fully exit the remaining position by year-end, and will 100% of those final proceeds be directed to the 'normalized' $1 billion annual buyback baseline?
GenAI Orchestration Layer Impact
At Investor Day, you highlighted GenAI ('AIG Assist') as a major productivity driver. Now that submissions are up materially with the Everest/Convex deals, is the GenAI 'orchestration layer' successfully preventing a proportional increase in headcount expenses?